I think it’s a great trial design. Allows running of a placebo arm without any ethical considerations - all patients will still get the standard corticosteroid treatment so would be no more disadvantaged than patients not in the trial.
However would still suck to be one of those unlucky ones to be in the trial but lose the coin flip and miss out on the stem cell therapy.
I wonder if there’s a small chance there’s plans to go for an approval application with the FDA if the p2 trial is successful - I know crazy idea.
I think it’s a great trial design. Allows running of a placebo...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 23813 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |